Background Scaling SARS-CoV-2 testing to meet demands of safe reopenings continues to
be plagued by assay costs and supply chain shortages. In response, we developed …

The contribution of the immune system to idiopathic pulmonary fibrosis (IPF) remains poorly
understood. While most sources agree that IPF does not result from a primary …

Dysregulated immune responses against the SARS-CoV-2 virus are instrumental in severe
COVID-19. However, the immune signatures associated with immunopathology are poorly …

The COVID-19 pandemic has affected more than 20 million people worldwide, with mortality
exceeding 800,000 patients. Risk factors associated with severe disease and mortality …

Rationale & Objective Acute kidney injury (AKI) is common in patients with coronavirus
disease 2019 (COVID-19) and associated with poor outcomes. Urinary biomarkers have been …

The COVID-19 pandemic has affected more than 20 million people worldwide with mortality
exceeding 800,000 patients. Risk factors associated with severe disease and mortality …

Rationale & Objective Patients hospitalized with COVID-19 are at increased risk for major
adverse kidney events (MAKE). We sought to identify plasma biomarkers predictive of MAKE in …

Objective Systemic sclerosis–associated interstitial lung disease (SSc‐ILD) is characterized
by variable clinical outcomes, activation of innate immune pattern‐recognition receptors (…

Sarcoidosis is a systemic granulomatous disease predominantly affecting the lungs. The
mechanisms promoting disease pathogenesis and progression are unknown, although …

Sarcoidosis is an unpredictable granulomatous disease in which African Americans
disproportionately experience aggressive phenotypes. Mitochondrial DNA (mtDNA) released by …